Back to search

Article

Clinical mechanism of ribavirin action in Hepatitis C treatment: insights from the STOPHCV-1 randomised trial

2026-04-15

Abstract excerpt

<h4>Background</h4> Ribavirin is a guanosine analogue with clinical antiviral activity against a range of RNA viruses including hepatitis C virus (HCV), respiratory syncytial virus and Lassa virus. Several potential mechanisms of action have been proposed, but there is limited data supporting them clinically. <h4>Methods</h4> We studied 196 HCV-infected participants from a trial of short-course directly antivira...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a0d8cee5-2f41-561f-87b8-40c175749fae
DOI
10.64898/2026.04.14.26350846
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical mechanism of ribavirin action in Hepatitis C treatment: insights from the STOPHCV-1 randomised trialDOI 10.64898/2026.04.14.26350846
Select a neighboring publication to make it the new centre.